New Treatment Landscape in MS — Preventing Long Term Disability Through High Efficacy Treatments in Early MS

home / stakeholder-summit / new-treatment-landscape-in-ms-preventing-long-term-disability-through-high-efficacy-treatments-in-early-ms

Neil Minkoff, MD; Maria Lopes, MD, MS; Nancy Ross, PharmD, BCACP, MSCS, CSP; Thomas Leist, MD; and Darin Okuda, MD explore opportunities for improving long-term patient outcomes in MS through earlier use of high efficacy therapies, including those of clinical and payer consideration.


CH LogoCenter for Biosimilars Logo